J Štěpán

13.4k total citations · 4 hit papers
228 papers, 8.7k citations indexed

About

J Štěpán is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J Štěpán has authored 228 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Orthopedics and Sports Medicine, 70 papers in Oncology and 55 papers in Molecular Biology. Recurrent topics in J Štěpán's work include Bone health and osteoporosis research (85 papers), Bone health and treatments (65 papers) and Bone Metabolism and Diseases (42 papers). J Štěpán is often cited by papers focused on Bone health and osteoporosis research (85 papers), Bone health and treatments (65 papers) and Bone Metabolism and Diseases (42 papers). J Štěpán collaborates with scholars based in Czechia, United States and Germany. J Štěpán's co-authors include V Pacovský, C. Christiansen, Olof Johnell, Pierre Delmas, Patrick Burkhardt, L. Joseph Melton, Ludmila P. Alexeeva, A Tosteson, Ego Seeman and Conrad Johnston and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J Štěpán

220 papers receiving 8.3k citations

Hit Papers

ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREEN... 1994 2026 2004 2015 1994 2000 2001 2019 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS
    1994 2.2k citations C. Christiansen, J Štěpán et al. profile →
  2. The Use of Biochemical Markers of Bone Turnover in Osteoporosis
    2000 548 citations Pierre D. Delmas, J Štěpán et al. Osteoporosis International profile →
  3. Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
    2001 505 citations Jordi Farrerons, J Štěpán et al. profile →
  4. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society
    2019 465 citations J Štěpán et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Štěpán Czechia 40 5.3k 3.2k 2.6k 1.7k 1.3k 228 8.7k
Charles H. Chesnut United States 34 6.2k 1.2× 3.7k 1.2× 2.6k 1.0× 1.2k 0.7× 831 0.6× 78 8.5k
Peter Selby United Kingdom 47 3.1k 0.6× 2.8k 0.9× 1.5k 0.6× 1.3k 0.8× 1.2k 0.9× 131 7.3k
Anthony B. Hodsman Canada 47 7.4k 1.4× 5.4k 1.7× 4.1k 1.6× 2.3k 1.4× 1.1k 0.9× 121 11.6k
Takayuki Hosoi Japan 47 3.2k 0.6× 1.8k 0.6× 3.1k 1.2× 1.4k 0.8× 1.1k 0.9× 222 8.9k
Salvatore Minisola Italy 56 4.3k 0.8× 3.2k 1.0× 2.1k 0.8× 1.9k 1.1× 2.8k 2.1× 307 10.1k
Steven T. Harris United States 39 9.7k 1.8× 6.2k 2.0× 3.9k 1.5× 2.9k 1.7× 1.5k 1.1× 76 12.9k
Bente Langdahl Denmark 48 4.7k 0.9× 3.3k 1.1× 3.9k 1.5× 1.4k 0.8× 790 0.6× 235 8.9k
José Zanchetta Argentina 42 8.4k 1.6× 6.6k 2.1× 5.1k 2.0× 2.0k 1.2× 1.2k 0.9× 114 12.3k
I. Fogelman United Kingdom 50 2.8k 0.5× 2.3k 0.7× 1.0k 0.4× 1.3k 0.8× 748 0.6× 229 7.4k
Mattias Lorentzon Sweden 52 5.3k 1.0× 2.1k 0.7× 2.8k 1.1× 2.5k 1.5× 1.1k 0.8× 259 10.3k

Countries citing papers authored by J Štěpán

Since Specialization
Citations

This map shows the geographic impact of J Štěpán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Štěpán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Štěpán more than expected).

Fields of papers citing papers by J Štěpán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Štěpán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Štěpán. The network helps show where J Štěpán may publish in the future.

Co-authorship network of co-authors of J Štěpán

This figure shows the co-authorship network connecting the top 25 collaborators of J Štěpán. A scholar is included among the top collaborators of J Štěpán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Štěpán. J Štěpán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šumová, Barbora, Lucie Andrés Cerezo, Hana Hulejová, et al.. (2020). S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity. BMC Rheumatology. 4(1). 13–13. 2 indexed citations
2.
Paschalis, Eleftherios P., John H. Krege, Sonja Gamsjaeger, et al.. (2018). Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques. Journal of Bone and Mineral Research. 33(12). 2230–2235. 9 indexed citations
3.
Štěpán, J, J. Rosa, & Karel Pavelká. (2016). [Raloxifene - an unexploited possibility of prevention and treatment of postmenopausal osteoporosis].. PubMed. 62(10). 781–788. 1 indexed citations
4.
Fahrleitner‐Pammer, Astrid, David B. Burr, Harald Dobnig, et al.. (2016). Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment. Bone. 89. 16–24. 16 indexed citations
5.
Malouf, Jorge, Umberto Tarantino, Pedro Alberto García-Hernández, et al.. (2016). Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial. Journal of Bone and Mineral Research. 32(5). 1040–1051. 35 indexed citations
6.
Poole, Kenneth, Andrew H. Gee, Fjóla Jóhannesdóttir, et al.. (2016). Focal osteoporosis defects play a key role in hip fracture. Bone. 94. 124–134. 65 indexed citations
7.
Paschalis, Eleftherios P., Sonja Gamsjaeger, N. Hassler, et al.. (2016). Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality. Bone. 95. 41–46. 50 indexed citations
8.
Treece, Graham M., P.M. Mayhew, Tom Turmezei, et al.. (2013). Precise 3D Localisation of Cortical Defects Associated with Subcapital, Trans-cervical and Trochanteric Hip Fractures in Life. Cambridge University Engineering Department Publications Database. 1 indexed citations
9.
Michalská, Dana, et al.. (2012). Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Osteoporosis International. 23(12). 2885–2891. 39 indexed citations
10.
Dobnig, Harald, J Štěpán, David B. Burr, et al.. (2009). Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate. Journal of Bone and Mineral Research. 24(12). 1998–2006. 48 indexed citations
11.
Recker, Robert R., Fernando Marín, Sophia Ish‐Shalom, et al.. (2009). Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research. 24(8). 1358–1368. 92 indexed citations
12.
Králíčková, Milena, Radek Šíma, Petr Martínek, et al.. (2007). [The leukemia inhibitory factor gene mutations in the population of infertile women: the heterozygote transition G to A on the position 3400 does not affect the outcome of the infertility treatment].. PubMed. 72(4). 293–8. 1 indexed citations
13.
Štěpán, J, David B. Burr, Imre Pávó, et al.. (2007). Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 41(3). 378–385. 114 indexed citations
14.
Jy, Reginster, S. Adámi, Péter L. Lakatos, et al.. (2005). Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Annals of the Rheumatic Diseases. 65(5). 654–661. 234 indexed citations
15.
Štěpán, J, Roman Pantůček, & Jiřı́ Doškař. (2004). Molecular diagnostics of clinically important staphylococci. Folia Microbiologica. 49(4). 353–386. 26 indexed citations
16.
Štěpán, J, et al.. (1997). [Spontaneous remission of corticosteroid osteopenia after successful surgical treatment of Cushing's syndrome. A cross-sectional study].. PubMed. 136(15). 464–7. 2 indexed citations
17.
Štěpán, J, K.‐H. William Lau, Subburaman Mohan, Frederick R. Singer, & David J. Baylink. (1990). Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: Evidence for a single structure. Biochemical and Biophysical Research Communications. 168(2). 792–800. 16 indexed citations
18.
Štěpán, J, et al.. (1980). Law & science : a selected bibliography. MIT Press eBooks. 1 indexed citations
19.
Štěpán, J, et al.. (1977). The source and clinical significance of serum alkaline phosphatases in patients treated by chronic dialysis.. PubMed. 75–9. 1 indexed citations
20.
Štěpán, J, et al.. (1976). Cystinosis with crystal-induced synovitis and arthropathy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(9-10). 347–55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles H. Chesnut Breakdown of academic impact, for papers by Peter Selby Breakdown of academic impact, for papers by Anthony B. Hodsman Breakdown of academic impact, for papers by Takayuki Hosoi Breakdown of academic impact, for papers by Salvatore Minisola Breakdown of academic impact, for papers by Steven T. Harris Breakdown of academic impact, for papers by Bente Langdahl Breakdown of academic impact, for papers by José Zanchetta Breakdown of academic impact, for papers by I. Fogelman Breakdown of academic impact, for papers by Mattias Lorentzon
Rankless by CCL
2026